Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Older Patients with Type 2 Diabetes: a Real-World Evidence Study
ConclusionsThis study's findings provide evidence of clinically-meaningful reductions in HbA1c, body weight, and SBP in older T2D patients on combined regimens. The dropout and hypoglycemia rate were minimal and treatment was tolerated well.
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Canada Health | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Nutrition | Obesity | Spain Health | Study | Weight Loss